# Intravenous Versus Intracoronary Use of Abciximab

> **NCT00685464** · NA · COMPLETED · sponsor: **University Hospital, Gentofte, Copenhagen** · enrollment: 355 (actual)

## Conditions studied

- Atherosclerosis
- Ischemic Heart Disease

## Interventions

- **DRUG:** Abciximab
- **DRUG:** Abciximab

## Key facts

- **NCT ID:** NCT00685464
- **Lead sponsor:** University Hospital, Gentofte, Copenhagen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** 2008-12
- **Final completion:** 2009-12
- **Target enrollment:** 355 (ACTUAL)
- **Last updated:** 2011-08-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00685464

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00685464, "Intravenous Versus Intracoronary Use of Abciximab". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT00685464. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*